Clene Inc. Common Stock
€5.765
EUR
Last updated on --.
24h volume61.31K
24h highest5.9359 EUR
24h lowest5.5567 EUR
24h Price movement+2.06%
CLNN recent prices
24 Hours
+2.06%+€0.11609
30 days
+13.76%+€0.69222
60 days
+38.07%+€1.577
90 days
+27.37%+€1.229
Key data
Previous close5.6495 EUR
Market cap75.82M EUR
Volume61.31K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.2529 EUR
Net income (FY)-28.82M EUR
Revenue (FY)115.23K EUR
Last report dateMay 14, 2026
About Clene Inc. Common Stock
HeadquartersSALT LAKE CITY
Employees (FY)79.00
Revenue per employee (FY)1.46K EUR
Net income per employee (FY)-364.78K EUR
Listed onNasdaq
CLNN conversion tables
 |  |
|---|---|
| 0.5 CLNN | 2.882 EUR |
| 1 CLNN | 5.765 EUR |
| 5 CLNN | 28.82 EUR |
| 10 CLNN | 57.65 EUR |
| |
|---|---|
| 0.5 EUR | 0.086721 CLNN |
| 1 EUR | 0.17344 CLNN |
| 5 EUR | 0.86721 CLNN |
| 10 EUR | 1.734 CLNN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CLNN is trading at €5.765, +2.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CLNN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CLNN is currently trading at €5.765, +2.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CLNN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CLNN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CLNN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CLNN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Clene Inc. Common Stock's market cap is currently 75.82M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume61.31K
24h highest5.9359 EUR
24h lowest5.5567 EUR
24h Price movement+2.06%
Start trade with CLNN Perpetual
Sign up to trade